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【Summany】
　Escitalopram is SSRI of having DAT (dopamine transporter ) inhibitory-action which is not. 
Having A10 nerve stimulus operation by the basic experiment which used Escitalopram is 
reported. However, until the present, a reason to the fact isn't made clear.
At this article, it supposed about the logical background. As a result, it was not straight course 
and the reinforcement of the indirect dopamine isolation through the 5HT1A autoreceptor on the 
somatodendritic of the serotonin nerve was thought of.
In the future, there is possibility that the reinforcement of the dopamine isolation by SSRI keeps 
effectivity to the chronic pain disease.
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図１　エスシタロプラム　ドパミンへの影響 ( ラット )
Schilstrom, B. et al: Synapse, 65, 357-367, 2011
図２　エスシタロプラムの A １０神経刺激作用









































































１）Schilström B., Konradsson-Geuken A. et 
al:  Effects of S-citalopram, citalopram, 
and R-citalopram on the firing patterns of 
dopamine neurons in the ventral tegmental 
area, N-methyl-D-aspartate receptor-
mediated transmission in the medial 
prefrontal cortex and cognitive function in 
the rat. Synapse 65： 357-367，2011
２）Marcus ,  MM. ,  Jardemark  K .  e t  a l : 
Augmentation by escitalopram, but not 
citalopram or R-citalopram, of the effects of 
low-dose risperidone: behavioral, biochemical, 
and electrophysiological evidence. Synapse 
66（4）： 277-290，2012
３）Penttilä J., Kajander J.　et al: Effects of 
fluoxetine on dopamine D2 receptors in 
the human brain: a positron emission 
tomography study with [11C]raclopride. Int 




５）Satomi Chiken., Asako Sato. et al: Dopamine 
D1 receptor -med ia ted  t ransmiss ion 
maintains information flow through the 
cortico-striato-entopeduncular direct 
pathway to release movements. Cerebral 
Cortex（電子版）、2015
６）Tritsch NX., Sabatini BL.：Dopaminergic 
modulation of synaptic transmission in 
cortex and striatum.  Neuron  76(1)：33-50，
2012
７）Wood PB: Mesol imbic dopaminergic 
mechanisms and pain control.  Pain 120：
230-240，2006
８）大久保恒正、安藤寿博　他：口腔顔面領域
の非器質性疼痛に対する抗うつ薬の作用機
序：第２報、高山赤十字病院紀要　39：17-
22，2015
